Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT03114995

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03114995
Other papers using this trial's data
  • Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial BMC cardiovascular disorders, 2018-10-22 DOI, PubMed 30348101, PMC6198526 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03114995. Randomized; double masking; primary purpose treatment. Start 2012-02-01 (actual); primary completion 2015-10-01 (actual). Results posted on 2018-06-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
Condition
Non-ST Elevation Myocardial Infarction
Intervention (Drug)
Tirofiban
Lead sponsor
Seoul National University Bundang Hospital (class: other)

Record details

Record id
cardio:ct-nct03114995
Content hash
891f103ed217feb1eb3b004b8d38272a67f1219b8d6e5db0f2d0a48024c59372